# Elekta secures up to €100 million EIB loan for treatment technology research

_Monday, August 31, 2026 at 9:18 AM EDT · Capital, Science · Latest · Tier 2 — Notable_

![Elekta secures up to €100 million EIB loan for treatment technology research — Primary](https://www.eu-startups.com/wp-content/uploads/2026/08/Untitled-design-2026-08-31T184514.417.jpg)

Elekta secured a European Investment Bank loan of up to €100 million to support a research programme in radiotherapy, radiosurgery, brachytherapy and treatment-planning software, according to EU-Startups. The loan can cover up to half of a roughly €200 million programme planned for 2026 through 2029, with most work based in Sweden and the Netherlands. Elekta develops precision radiation-medicine systems for cancer and certain neurological conditions.

## Sources

- [EU-Startups](https://www.eu-startups.com/2026/08/stockholm-based-elekta-secures-e100-million-eib-loan-to-advance-cancer-and-neurological-treatments/)

---
Canonical: https://techandbusiness.org/newswire/KBZpIbVmvJ-pBmUVhWHAvP
Retrieved: 2026-08-31T17:02:17.629Z
Publisher: Tech & Business (techandbusiness.org)